{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:34:59Z","timestamp":1792794899578,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1124\/dmd.122.000864","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:50:12Z","timestamp":1648554612000},"page":"741-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs"],"prefix":"10.1016","volume":"50","author":[{"given":"QingLiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiTing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CuiTong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LanLan","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WuShuang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.122.000864_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1124\/dmd.106.009977","article-title":"Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes","volume":"34","author":"Carr","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/dmd.119.086637","article-title":"Stereoselective oxidation kinetics of deoxycholate in recombinant and microsomal CYP3A Enzymes: deoxycholate 19-hydroxylation is an in vitro marker of CYP3A7 activity","volume":"47","author":"Chen","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/acs.molpharmaceut.8b00941","article-title":"Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics","volume":"16","author":"Couto","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.122.000864_bib4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1124\/dmd.109.027763","article-title":"3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid","volume":"37","author":"Deo","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/00498250500489968","article-title":"Enzymatic characteristics of CYP3A5 and CYP3A4: a comparison of in vitro kinetic and drug-drug interaction patterns","volume":"36","author":"Emoto","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.122.000864_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0022-3565(24)37146-0","article-title":"Isolation, heterologous expression and functional characterization of a novel cytochrome P450 3A enzyme from a canine liver cDNA library","volume":"283","author":"Fraser","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.000864_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1989.tb03516.x","article-title":"The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction","volume":"28","author":"Ged","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.122.000864_bib8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(94)90543-6","article-title":"Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily","volume":"47","author":"Gorski","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.000864_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.05.015","article-title":"Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam","volume":"86","author":"Grimsley","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.000864_bib10","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1021\/bi00266a045","article-title":"Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone","volume":"21","author":"Guengerich","year":"1982","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.122.000864_bib11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1124\/dmd.116.070805","article-title":"CYP3A specifically catalyzes 1\u03b2-hydroxylation of deoxycholic acid: characterization and enzymatic synthesis of a potential novel urinary biomarker for CYP3A activity","volume":"44","author":"Hayes","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib12","first-page":"1068","article-title":"Drug interaction between simvastatin and itraconazole in male and female rats","volume":"29","author":"Ishigami","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1124\/dmd.117.078055","article-title":"Digging deeper into CYP3A testosterone metabolism: kinetic, regioselectivity, and stereoselectivity differences between CYP3A4\/5 and CYP3A7","volume":"45","author":"Kandel","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib14","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1016\/S0021-9258(19)76460-6","article-title":"P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate","volume":"262","author":"Kitada","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.122.000864_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0006-2952(87)90350-9","article-title":"Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations","volume":"36","author":"Kitada","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.000864_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.31.7.833","article-title":"Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat","volume":"31","author":"Kobayashi","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/03602530701690374","article-title":"Drugs as CYP3A probes, inducers, and inhibitors","volume":"39","author":"Liu","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.122.000864_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/dmd.108.025312","article-title":"Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase","volume":"37","author":"Locuson","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0009-2797(01)00162-4","article-title":"Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog","volume":"134","author":"Lu","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.122.000864_bib20","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.apsb.2021.01.007","article-title":"CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics","volume":"11","author":"Lu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.122.000864_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/03602532.2013.765445","article-title":"Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics","volume":"45","author":"Martinez","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.122.000864_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41598-019-56660-z","article-title":"Pharmacogenomics of poor drug metabolism in greyhounds: cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization","volume":"10","author":"Martinez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.122.000864_bib23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/dmd.119.088070","article-title":"Absolute quantitation of drug-metabolizing cytochrome P450 enzymes and accessory proteins in dog liver microsomes using label-free standard-free analysis reveals interbreed variability","volume":"47","author":"Martinez","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00439-019-02020-w","article-title":"Personalized medicine: going to the dogs?","volume":"138","author":"Mealey","year":"2019","journal-title":"Hum Genet"},{"key":"10.1124\/dmd.122.000864_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-4731(76)90166-7","article-title":"Cortisol metabolites in dog plasma","volume":"7","author":"Miyabo","year":"1976","journal-title":"J Steroid Biochem"},{"key":"10.1124\/dmd.122.000864_bib26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/clpt.2008.50","article-title":"Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism","volume":"83","author":"Muruganandan","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.000864_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0304-4165(97)00156-6","article-title":"Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells","volume":"1380","author":"Ohmori","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.122.000864_bib28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)35332-7","article-title":"Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms","volume":"292","author":"Perloff","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.000864_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx500444e","article-title":"Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals","volume":"28","author":"Rendic","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.122.000864_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1124\/dmd.32.2.186","article-title":"Differential enantioselectivity and product-dependent activation and inhibition in metabolism of verapamil by human CYP3As","volume":"32","author":"Shen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/dmd.31.9.1161","article-title":"Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450","volume":"31","author":"Shou","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2006.03.002","article-title":"New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology","volume":"11","author":"Stevens","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1124\/dmd.122.000864_bib33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/mol.107.043869","article-title":"Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes","volume":"73","author":"van Waterschoot","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.000864_bib34","doi-asserted-by":"crossref","first-page":"12536","DOI":"10.1021\/bi980895g","article-title":"Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe","volume":"37","author":"Wang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.122.000864_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1006\/bbrc.2001.4505","article-title":"Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43","volume":"281","author":"Westlind","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.122.000864_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd1851","article-title":"Predicting in vivo drug interactions from in vitro drug discovery data","volume":"4","author":"Wienkers","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.122.000864_bib37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","article-title":"Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.122.000864_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/dmd.121.000385","article-title":"Tertiary oxidation of deoxycholate is predictive of CYP3A activity in dogs","volume":"49","author":"Zeng","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/dmd.118.085670","article-title":"Continuum of host-gut microbial co-metabolism: host CYP3A4\/3A7 are responsible for tertiary oxidations of deoxycholate species","volume":"47","author":"Zhang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.000864_bib41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1124\/dmd.110.033068","article-title":"Expression and characterization of dog cytochrome P450 2A13 and 2A25 in baculovirus-infected insect cells","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624008183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624008183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.122.000864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:54:12Z","timestamp":1739955252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624008183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0090955624008183"],"URL":"https:\/\/doi.org\/10.1124\/dmd.122.000864","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.122.000864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}